The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention

Conclusion:
Our study revealed that 12-hour tirofiban administration versus 24-hour tirofiban administration in STEMI who underwent primary PCI was similar with respect to in-hospital efficacy and safety and major adverse cardiac events during 6-month follow-up.

Source: Clinical and Applied Thrombosis/Hemostasis - October 5, 2015 Category: Hematology Authors: Topcu, S., Karal, H., Kaya, A., Bakirci, E. M., Tanboga, I. H., Kurt, M., Aksakal, E., Acikel, M., Sevimli, S. Tags: Original Articles Source Type: research